FOLH1 and prostate carcinoma: The prostate-specific membrane antigen (PSMA), an enzyme expressed on the surface of prostate cancer cells, plays a crucial role in prostate cancer progression by modulating the phosphoinositide 3-kinase (PI3K) pathway and glutamine production 17, 18.